MedTrace Logo

Prevalence and Risk Factors of COVID-19 in the Upper Silesian Agglomeration

NCT04627623 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 6000

Last updated 2020-11-17

No results posted yet for this study

Summary

Project is designed as a comprehensive population-based epidemiological study in Upper-Silesian Conurbation (Poland) aiming at:

1. analysis of available data on incidence and mortality due to COVID-19 and
2. estimation of the occurrence of viral infection SARS-CoV-2 as revealed by the results of serological test (ELISA: IgM, IgG), with assessment of risk factors.

The project's objectives are: to assess incidence and mortality due COVID-19 according to sex, age and coexisting diseases; to determine the level of potential "underdiagnosis" of the magnitude of COVID-19 mortality using vital statistics data for Upper-Silesian Conurbation; to assess the prevalence of SARS-CoV-2 based on the level of seropositivity in Upper-Silesian Conurbation; to identify host-related and environmental risk factors if the infection. Analysis of existing data will include monthly records on incidence and mortality over the period 01.01.2020-31.12.2020 and comparison of the findings with the monthly records of 2018 and 2019, for the same population. Cross-sectional epidemiological study will be located in three towne (Katowice, Sosnowiec, Gliwice). In each town a representative age-stratified sample of 2000 subjects will undergo questionnaire assessment and serological examination performed by serological test. The project corresponds with analogous population-based studies on COVID-19 in a number of countries and responds to the WHO recommendation in that field.

Conditions

  • Covid19
  • Respiratory Tract Infections
  • Severe Acute Respiratory Syndrome
  • Corona Virus Infection
  • RNA Virus Infections
  • Virus Disease
  • Respiratory Tract Disease

Interventions

DIAGNOSTIC_TEST

IgM and IgG antibodies assay

5 ml venous blood sample collection to assay IgM and IgM against COVID19

Sponsors & Collaborators

  • Medical University of Silesia

    lead OTHER

Principal Investigators

  • Jan E Zejda, Prof · Medical University of Silesia in Katowice Poland

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-06-22
Primary Completion
2021-03-22
Completion
2021-04-22

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04627623 on ClinicalTrials.gov